EHA Lymphoma Group
The EHA Lymphoma Group is a Scientific Working Group which was established in 2014.
The mission of the EHA Lymphoma Group is to establish a network of scientists and hematologists covering all major areas of lymphoma research (including Hodgkin's lymphoma, indolent and aggressive non-Hodgkin’s lymphoma and Waldenström’s macroglobulinemia), ultimately leading to:
- Improvement of the understanding of the pathogenesis/biology of lymphoma.
- Improvement of the diagnostics in patients with lymphoma (including new imaging techniques and molecular characterization of lymphoma).
- Improvement of the (targeted) treatment of lymphoma.
- Closer collaboration between lymphoma groups.
- Optimal exchange and dissemination of knowledge and information; including improvement in education.
The EHA Lymphoma Group aims to become an organization that facilitates investigator-initiated, cross-border clinical trials and registry studies across different lymphoma subtypes, with a focus on rare types of lymphoma. In 2017 the EHA Lymphoma Group and the European Mantle Cell Network merged. A closer collaboration with ELI, the European Lymphoma Institute is foreseen.
For more information on the EHA Lymphoma Group: Click here
Become a registered member of this Scientific Working Group: Apply here